News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Apr 27, 2022
2022
Press Release Non-regulatory

Elicera Therapeutics successfully concludes preclinical proof-of-concept studies for oncolytic virus ELC-201 confirming the proposed mode-of-action

Non-regulatory Press Release
Read more
Apr 27, 2022
2022
News

Interviews with Magnus Essand and Gunilla Enblad at SWECARNET's education day April 27

News
Read more
Apr 26, 2022
2022
Press Release Regulatory

Elicera Therapeutics AB (publ) Interim Report 1 January – 31 March 2022

Regulatory Press Release
Read more
Apr 10, 2022
2022
News

Upsala Nya Tidning writes about Elicera's research and upcoming clinical studies

News
Read more
Apr 7, 2022
2022
News

Nordic Life Science News writes about the iTANK-publication

News
Read more
Apr 6, 2022
2022
News

Biostock makes a video interview with CSO, professor Magnus Essand, on the iTANK, publication.

News
Read more
Apr 4, 2022
2022
Press Release Regulatory

Elicera Therapeutics publishes scientific article in Nature Biomedical Engineering on the iTANK-platform and data indicating its universal compatibility with other CAR T-cell therapies

Regulatory Press Release
Read more
Mar 1, 2022
2022
News

Elicera featured in Life Science Sweden's perspective on CAR T-cell therapies

News
Read more
Feb 24, 2022
2022
Press Release Non-regulatory

Elicera Therapeutics’ Chief Scientific Officer, Professor Magnus Essand, to present at SWECARNET’s Educational Day 2022

Non-regulatory Press Release
Read more
Feb 4, 2022
2022
Press Release Regulatory

Elicera Therapeutics publishes annual report for 2021

Regulatory Press Release
Read more
Jan 25, 2022
2022
Press Release Regulatory

Elicera Therapeutics AB (publ) Interim Report 1 January – 31 December 2021

Regulatory Press Release
Read more
Jan 20, 2022
2022
News

Interview and summary of 2021 in Biostock

News
Read more
Jan 19, 2022
2022
News

Elicera in Nordic Life Science - Vinnova grant

News
Read more
Jan 18, 2022
2022
Press Release Non-regulatory

Elicera Therapeutics secures 5 million SEK in funding from Vinnova to develop an automated CAR T-cell manufacturing process

Non-regulatory Press Release
Read more
Jan 14, 2022
2022
Press Release Regulatory

The Nomination Committee for Elicera Therapeutics proposes re-election of Board

Regulatory Press Release
Read more
Jan 5, 2022
2022
Press Release Non-regulatory

Elicera Therapeutics strengthens IP protection for ELC-100 through acquisition of patent from Immunicum

Non-regulatory Press Release
Read more
Jan 5, 2022
2022
News

Nordic Life Science News writes about Elicera's patent acquisition from Immunicum

News
Read more
Dec 15, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics enters into agreement with Baylor College of Medicine for contract manufacturing of next generation oncolytic virus, ELC-201

Non-regulatory Press Release
Read more
Nov 18, 2021
2021
Press Release Regulatory

Elicera Therapeutics AB (publ) Interim Report 1 January – 30 September 2021

Regulatory Press Release
Read more
Nov 9, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics enters agreement with BioNTech for contract manufacturing of viral vectors for CAR T-cell therapy

Non-regulatory Press Release
Read more

Sign up for Press Releases

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our Integrity policy.